Recent experiment of animal model and clinic of AMD towards VEGF suggested that a potential role of VEGF was a key angiogenic factor in the development of CNV in late stage AMD, and more researchers suggested that polymorphisms in the VEGF gene might bring about risk of AMD and effect on anti-VEGF therapy. This evidence concerns the gene VEGFA and age-related macular degeneration.